Benzodiazepine high-doses: The need for an accurate definition.

anxiolytics benzodiazepine high-dose use hypnotics long-term use

Journal

International journal of methods in psychiatric research
ISSN: 1557-0657
Titre abrégé: Int J Methods Psychiatr Res
Pays: United States
ID NLM: 9111433

Informations de publication

Date de publication:
12 2021
Historique:
revised: 02 07 2021
received: 25 02 2021
accepted: 14 07 2021
pubmed: 1 8 2021
medline: 15 12 2021
entrez: 31 7 2021
Statut: ppublish

Résumé

A clear definition of what we understand of high-dose misuse or of a 'markedly increased dose' (as stated by the DSM-5) is important and past definitions may be inadequate. The aim of this review is to describe the different definitions used and to test these definitions for their accuracy. A narrative PubMed literature review was conducted based on articles published between 1 January 1990 and 31 December 2020 describing benzodiazepines (in MeSH Terms or MeSH Major Topic) and high-dose (or high-dosage). Specific definitions were applied to a population sample to show how definitions affect high-dose benzodiazepine prevalence. Multiples of an equivalent-diazepam dose or of the World Health Organization 'defined daily dosage' were used more frequently than the overstep of the recommended maximum therapeutic dosage as a cut-off point. High-dose use is rare but the prevalence in the general population varies among studies, mainly due to different definitions, making both clinical and epidemiological comparisons between studies difficult. Defining a high-dose user as a person who takes at least a higher dose than the maximum usual therapeutic dose over a defined period of time therefore appears to be clinically more consistent.

Identifiants

pubmed: 34331787
doi: 10.1002/mpr.1888
pmc: PMC8633930
doi:

Substances chimiques

Benzodiazepines 12794-10-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1888

Informations de copyright

© 2021 The Authors. International Journal of Methods in Psychiatric Research published by John Wiley & Sons Ltd.

Références

Psychother Psychosom. 2015;84(5):262-4
pubmed: 26278000
Scand J Prim Health Care. 2015;33(4):252-9
pubmed: 26683285
Intern Med J. 2014 Jan;44(1):57-64
pubmed: 24450521
Expert Opin Drug Saf. 2018 May;17(5):451-456
pubmed: 29621907
Addiction. 2011 Dec;106(12):2086-109
pubmed: 21714826
Compr Psychiatry. 2002 Nov-Dec;43(6):438-42
pubmed: 12439830
Intern Emerg Med. 2021 Mar;16(2):521-523
pubmed: 32875478
Addiction. 2000 Feb;95(2):245-50
pubmed: 10723853
Sleep Med. 2012 Aug;13(7):893-7
pubmed: 22704401
Ugeskr Laeger. 1994 Oct 17;156(42):6171-4
pubmed: 7998351
Eur Addict Res. 2020;26(4-5):274-282
pubmed: 32570244
Pain. 2019 Apr;160(4):852-859
pubmed: 30531310
Drug Alcohol Depend. 1993 Mar;32(1):15-23
pubmed: 8097996
Drug Alcohol Depend. 1997 May 2;45(3):207-12
pubmed: 9179522
J Trauma Stress. 2007 Oct;20(5):909-14
pubmed: 17955537
J Psychiatr Res. 2018 Feb;97:94-100
pubmed: 29223863
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Psychiatr Serv. 2003 Jul;54(7):1006-11
pubmed: 12851438
Dtsch Arztebl Int. 2015 Jan 5;112(1-2):1-7
pubmed: 25613443
Br J Psychiatry. 2021 Mar;218(3):125-127
pubmed: 33040746
Can J Psychiatry. 1991 Feb;36(1):62-73
pubmed: 1674225
Intern Emerg Med. 2019 Nov;14(8):1271-1278
pubmed: 31076977
Int J Cancer. 2017 Feb 1;140(3):513-525
pubmed: 27667780
PLoS Med. 2018 Aug 7;15(8):e1002635
pubmed: 30086134
Psychother Psychosom. 2015;84(5):273-83
pubmed: 26278327
Clin Pharmacol Ther. 1984 Oct;36(4):527-33
pubmed: 6434221
J Subst Abuse Treat. 1991;8(1-2):9-17
pubmed: 1675694
Int J Environ Res Public Health. 2017 Jan 04;14(1):
pubmed: 28054975
Drug Alcohol Depend. 2003 Jun 5;70(3):309-14
pubmed: 12757968
Can Fam Physician. 1985 Sep;31:1591-6
pubmed: 21274169
Int J Methods Psychiatr Res. 2021 Dec;30(4):e1888
pubmed: 34331787
Br J Addict. 1987 Dec;82(12):1329-34
pubmed: 2892524
Psychother Psychosom. 2002 Sep-Oct;71(5):263-8
pubmed: 12207106
Zentralbl Chir. 2016 Feb;141(1):75-81
pubmed: 26670380
Drug Alcohol Depend. 2009 Sep 1;104(1-2):140-6
pubmed: 19515515
Epilepsia. 2009 May;50(5):1158-66
pubmed: 19170737
Acta Psychiatr Scand. 1997 Aug;96(2):85-93
pubmed: 9272191
Addiction. 1996 Aug;91(8):1179-86
pubmed: 8828245
Addict Behav. 2013 Oct;38(10):2575-80
pubmed: 23811061
J Gen Intern Med. 2016 Sep;31(9):1027-34
pubmed: 27177914
J Am Acad Psychiatry Law. 2016 Sep;44(3):328-37
pubmed: 27644866
J Clin Psychopharmacol. 2005 Dec;25(6):600-4
pubmed: 16282847
Pain. 2020 May;161(5):1083-1091
pubmed: 31923046
Nord J Psychiatry. 2014 Feb;68(2):107-16
pubmed: 23521539
Drug Alcohol Depend. 2014 Sep 1;142:105-9
pubmed: 25001277
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Apr;53(4):319-25
pubmed: 20198358
Psychiatry Res. 2016 Mar 30;237:201-7
pubmed: 26805564
Addiction. 2010 Nov;105(11):1870-4
pubmed: 20456294
Am Fam Physician. 1984 Nov;30(5):139-47
pubmed: 6149682
Eur Respir J. 2018 Dec 6;52(6):
pubmed: 30309973
Ther Drug Monit. 2016 Apr;38(2):253-8
pubmed: 26580099
Medicine (Baltimore). 2015 Sep;94(37):e1571
pubmed: 26376408
Fundam Clin Pharmacol. 2016 Feb;30(1):82-92
pubmed: 26555674
Psychogeriatrics. 2020 Jul;20(4):447-457
pubmed: 32032470
Neurol Sci. 2017 Jan;38(1):137-142
pubmed: 27730361
J Multidiscip Healthc. 2016 Oct 19;9:547-555
pubmed: 27799781
Addiction. 1999 Jan;94(1):97-107
pubmed: 10665101
Fam Pract. 2003 Aug;20(4):370-2
pubmed: 12876104
Alcohol Alcohol. 2003 Nov-Dec;38(6):613-8
pubmed: 14633651
Med J Aust. 2013 Mar 4;198(4):206-9
pubmed: 23451965
J Neural Transm (Vienna). 2021 Jul;128(7):1109-1119
pubmed: 33331955
Psychother Psychosom. 2015;84(5):259-61
pubmed: 26277902
Nervenarzt. 1996 May;67(5):381-6
pubmed: 9005346
Compr Ther. 1986 Oct;12(10):53-60
pubmed: 2877768
BMC Geriatr. 2001;1:4
pubmed: 11741508
PLoS One. 2015 Nov 10;10(11):e0142057
pubmed: 26556055
Psychiatry Res. 2012 Aug 15;198(3):457-62
pubmed: 22424905
BMC Psychiatry. 2015 May 13;15:116
pubmed: 25968120
J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):492-8
pubmed: 19196642
J Psychopharmacol. 2016 Oct;30(10):1047-53
pubmed: 27166362
Harm Reduct J. 2016 Jan 08;13:1
pubmed: 26743909
Soc Psychiatry Psychiatr Epidemiol. 2002 Mar;37(3):139-44
pubmed: 11990011
Psychother Psychosom. 2020;89(5):283-306
pubmed: 32259826
J Clin Psychopharmacol. 1990 Aug;10(4 Suppl):68S-75S
pubmed: 2229465
Eur Psychiatry. 2015 Nov;30(8):1037-47
pubmed: 26545257
J Clin Psychopharmacol. 1996 Feb;16(1):51-7
pubmed: 8834419
Drug Alcohol Depend. 1980 Dec;6(6):365-71
pubmed: 6110530
J Clin Psychopharmacol. 1992 Apr;12(2):124-7
pubmed: 1315343
Drug Alcohol Depend. 2020 May 1;210:107962
pubmed: 32220698

Auteurs

Jean-Marc Cloos (JM)

Department of Psychiatry, Hôpitaux Robert Schuman, Luxembourg, Luxembourg.

Christopher Y S Lim Cow (CYS)

Department of Psychiatry, Hôpitaux Robert Schuman, Luxembourg, Luxembourg.

Valéry Bocquet (V)

Department of Public Health, Competence Centre in Methodology and Statistics, Luxembourg Institute of Health, Luxembourg.
Unité de Soutien Méthodologique, CHU La Réunion, Saint-Denis, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH